All sections · Part XIII: Protected Cell Companies · Sub-Part IV: Assets and Liabilities
230 债权人的立场
(1) 在不违反任何代位权协议条款的情况下，受保护细胞公司的债权人的权利应与第233和234条规定的义务相同。
(2) 在符合任何代位权协议条款的前提下，受保护电池公司的债权人除本节和第231、232、233和234节规定的权利外，不享有任何其他权利。
(3) 在受保护电池公司达成的任何交易中，应包括以下条款和条件（除非以书面形式明确排除）------。
(a) 任何一方在任何诉讼或其他情况下或在任何地方均不得要求任何受保护资产承担责任。
(b) 如果任何一方以任何方式或在任何地方成功地使受保护资产承担责任，该方有责任向本公司支付相当于其由此获得的利益价值的金额；以及
(c) 如果任何一方以任何方式成功地查封或扣押任何受保护资产，或以其他方式强制执行，该方须为本公司并代表本公司以信托方式持有该资产或其收益，并须将该资产或收益分开，并可识别为该信托财产。
(4) 受保护电池公司因第(3)(c)款所述的这种信托而收取的任何金额，应计入根据第(3)(b)款规定的隐含条款所规定的任何并行责任。
(5)根据第(3)(b)或(3)(c)款提及的隐含时限或其他方式或在这些款项提及的情况下从受保护单元公司收回的任何资产或款项，在扣除或支付所有收回费用后，应由该公司用于赔偿受影响的单元或（视情况而定）核心。
(6) 如果受保护的资产被用于执行不可归属的责任，而这些资产或与这些资产有关的报酬不能以其他方式返还给受影响的单元或核心（视情况而定），本公司应------。
(a) 安排或聘请一名独立专家，作为专家而不是仲裁员，证明受影响的电池或(视情况而定)核心资产的损失价值；以及
(b) 从责任归属的单元或核心资产中转移或支付损失的资产价值，足以恢复受影响的单元或(视情况而定)核心的资产或金额。
(7) 本节适用于域外。
(2) 在符合任何代位权协议条款的前提下，受保护电池公司的债权人除本节和第231、232、233和234节规定的权利外，不享有任何其他权利。
(3) 在受保护电池公司达成的任何交易中，应包括以下条款和条件（除非以书面形式明确排除）------。
(a) 任何一方在任何诉讼或其他情况下或在任何地方均不得要求任何受保护资产承担责任。
(b) 如果任何一方以任何方式或在任何地方成功地使受保护资产承担责任，该方有责任向本公司支付相当于其由此获得的利益价值的金额；以及
(c) 如果任何一方以任何方式成功地查封或扣押任何受保护资产，或以其他方式强制执行，该方须为本公司并代表本公司以信托方式持有该资产或其收益，并须将该资产或收益分开，并可识别为该信托财产。
(4) 受保护电池公司因第(3)(c)款所述的这种信托而收取的任何金额，应计入根据第(3)(b)款规定的隐含条款所规定的任何并行责任。
(5)根据第(3)(b)或(3)(c)款提及的隐含时限或其他方式或在这些款项提及的情况下从受保护单元公司收回的任何资产或款项，在扣除或支付所有收回费用后，应由该公司用于赔偿受影响的单元或（视情况而定）核心。
(6) 如果受保护的资产被用于执行不可归属的责任，而这些资产或与这些资产有关的报酬不能以其他方式返还给受影响的单元或核心（视情况而定），本公司应------。
(a) 安排或聘请一名独立专家，作为专家而不是仲裁员，证明受影响的电池或(视情况而定)核心资产的损失价值；以及
(b) 从责任归属的单元或核心资产中转移或支付损失的资产价值，足以恢复受影响的单元或(视情况而定)核心的资产或金额。
(7) 本节适用于域外。
Translation for information only. Only the English original is legally binding.
Original wording (English, legally binding): Position of creditors
(1) Subject to the terms of any recourse agreement, the rights of creditors of
a protected cell company correspond with the liabilities provided for in
sections 233 and 234.
(2) Subject to the terms of any recourse agreement, no creditor of a protected
cell company has any rights other than the rights referred to in this section
and in sections 231, 232, 233 and 234.
(3) There is implied (except in so far as the same is expressly excluded in
writing) in every transaction entered into by a protected cell company the
following terms —
(a) that no party shall seek, whether in any proceedings or by any
other means whatsoever or wherever, to make or attempt to
make liable any protected assets;
(b) that if any party succeeds by any means whatsoever or
wherever in making liable any protected assets, that party shall
be liable to the company to pay a sum equal to the value of the
benefit thereby obtained by him; and
(c) that if any party succeeds in seizing or attaching by any means
or otherwise levying execution against any protected assets,
that party shall hold those assets or their proceeds on trust for
and on behalf of the company and shall keep those assets or
proceeds separate and identifiable as such trust property.
(4) All sums recovered by a protected cell company as a result of any such
trust as is described in subsection (3)(c) shall be credited against any
concurrent liability imposed pursuant to the implied term set out in
subsection (3)(b).
(5) Any asset or sum recovered by a protected cell company pursuant to the
implied term set out in subsection (3)(b) or (3)(c) or by any other means
whatsoever or wherever in the events referred to in those subsections
shall, after the deduction or payment of any costs of recovery, be applied
by the company so as to compensate the cell affected or (as the case may
be) the core.
(6) In the event of any protected assets being taken in execution in respect of
a liability to which they are not attributable, and in so far as such assets
or compensation in respect thereof cannot otherwise be restored to the
cell affected or (as the case may be) the core, the company shall —
(a) cause or procure an independent expert, acting as expert and not
as arbitrator, to certify the value of the assets lost to the cell
affected or (as the case may be) the core; and
(b) transfer or pay, from the cellular or core assets to which the
liability was attributable, to the cell affected or (as the case may
be) the core, assets or sums sufficient to restore to the cell
affected or (as the case may be) the core, the value of the assets
lost.
(7) This section has extra-territorial application.
a protected cell company correspond with the liabilities provided for in
sections 233 and 234.
(2) Subject to the terms of any recourse agreement, no creditor of a protected
cell company has any rights other than the rights referred to in this section
and in sections 231, 232, 233 and 234.
(3) There is implied (except in so far as the same is expressly excluded in
writing) in every transaction entered into by a protected cell company the
following terms —
(a) that no party shall seek, whether in any proceedings or by any
other means whatsoever or wherever, to make or attempt to
make liable any protected assets;
(b) that if any party succeeds by any means whatsoever or
wherever in making liable any protected assets, that party shall
be liable to the company to pay a sum equal to the value of the
benefit thereby obtained by him; and
(c) that if any party succeeds in seizing or attaching by any means
or otherwise levying execution against any protected assets,
that party shall hold those assets or their proceeds on trust for
and on behalf of the company and shall keep those assets or
proceeds separate and identifiable as such trust property.
(4) All sums recovered by a protected cell company as a result of any such
trust as is described in subsection (3)(c) shall be credited against any
concurrent liability imposed pursuant to the implied term set out in
subsection (3)(b).
(5) Any asset or sum recovered by a protected cell company pursuant to the
implied term set out in subsection (3)(b) or (3)(c) or by any other means
whatsoever or wherever in the events referred to in those subsections
shall, after the deduction or payment of any costs of recovery, be applied
by the company so as to compensate the cell affected or (as the case may
be) the core.
(6) In the event of any protected assets being taken in execution in respect of
a liability to which they are not attributable, and in so far as such assets
or compensation in respect thereof cannot otherwise be restored to the
cell affected or (as the case may be) the core, the company shall —
(a) cause or procure an independent expert, acting as expert and not
as arbitrator, to certify the value of the assets lost to the cell
affected or (as the case may be) the core; and
(b) transfer or pay, from the cellular or core assets to which the
liability was attributable, to the cell affected or (as the case may
be) the core, assets or sums sufficient to restore to the cell
affected or (as the case may be) the core, the value of the assets
lost.
(7) This section has extra-territorial application.
